CDMO
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
Bora Pharmaceuticals Acquires 30.5% Stake in Tanvex Biopharma, Becomes Largest Corporate Shareholder
2024-08-28
BIO Asia-Taiwan’s CGT Vax Discovery Symposium—Collaborations, Innovations and Emerging Tech in Taiwan’s Vaccine Industry
2024-08-19
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Taiwan’s Biotech Brilliance Shines at BIO 2023: Unveiling Cutting-Edge Discoveries and Strategic Partnerships
2023-06-20